Načítá se...
Memantine for dementia in people with Down syndrome
BACKGROUND: Alzheimer's dementia (AD) is the most common form of dementia in people with Down Syndrome (DS). There is an understanding that an increase in L‐glutamate contributes to the pathogenesis of cerebral ischemias and AD. Memantine acts as an antagonist of N‐methyl‐D‐aspartate (NMDA) typ...
Uloženo v:
| Vydáno v: | Cochrane Database Syst Rev |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Ltd
2009
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7197456/ https://ncbi.nlm.nih.gov/pubmed/19160343 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD007657 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|